Applied DNA Sciences Inc (APDN)
0.1583
-0.01
(-4.06%)
USD |
NASDAQ |
Nov 21, 16:00
0.1558
0.00 (0.00%)
Pre-Market: 08:34
Applied DNA Sciences Net Income (Quarterly): 1.880M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.880M |
| March 31, 2024 | -4.470M |
| December 31, 2023 | -1.105M |
| September 30, 2023 | -3.592M |
| June 30, 2023 | -3.100M |
| March 31, 2023 | 0.5883M |
| December 31, 2022 | -3.843M |
| September 30, 2022 | -0.6632M |
| June 30, 2022 | -1.124M |
| March 31, 2022 | -1.759M |
| December 31, 2021 | -4.722M |
| September 30, 2021 | -4.511M |
| June 30, 2021 | -3.449M |
| March 31, 2021 | -1.517M |
| December 31, 2020 | -4.810M |
| September 30, 2020 | -4.123M |
| June 30, 2020 | -3.289M |
| March 31, 2020 | -2.952M |
| December 31, 2019 | -2.663M |
| September 30, 2019 | -1.224M |
| June 30, 2019 | -1.478M |
| March 31, 2019 | -2.687M |
| December 31, 2018 | -3.234M |
| September 30, 2018 | -3.475M |
| June 30, 2018 | -2.888M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.146M |
| December 31, 2017 | -3.184M |
| September 30, 2017 | -2.855M |
| June 30, 2017 | -2.611M |
| March 31, 2017 | -3.429M |
| December 31, 2016 | -3.961M |
| September 30, 2016 | -2.415M |
| June 30, 2016 | -3.367M |
| March 31, 2016 | -3.468M |
| December 31, 2015 | -2.926M |
| September 30, 2015 | -0.496M |
| June 30, 2015 | -1.671M |
| March 31, 2015 | -1.886M |
| December 31, 2014 | -7.829M |
| September 30, 2014 | -2.106M |
| June 30, 2014 | -1.919M |
| March 31, 2014 | -2.750M |
| December 31, 2013 | -6.292M |
| September 30, 2013 | -3.718M |
| June 30, 2013 | -2.136M |
| March 31, 2013 | -3.128M |
| December 31, 2012 | -8.705M |
| September 30, 2012 | -1.767M |
| June 30, 2012 | -1.430M |
| March 31, 2012 | -1.544M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.810M
Minimum
Dec 2020
1.880M
Maximum
Jun 2024
-2.591M
Average
-3.100M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Fonar Corp | 3.135M |
| XWELL Inc | -4.75M |
| ProPhase Labs Inc | -6.587M |
| Veracyte Inc | 15.16M |
| OncoCyte Corp | -13.49M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.7975M |
| Total Expenses (Quarterly) | 4.144M |
| EPS Diluted (Quarterly) | 0.47 |
| Enterprise Value | -8.969M |
| Gross Profit Margin (Quarterly) | 30.75% |
| Earnings Yield | -7.57K% |
| Normalized Earnings Yield | -10658.74 |